Gaithersburg-based Viela Bio files for $150M IPO

Viela Bio, the MedImmune spinout that has attracted more than $300 million in venture capital, filed for a $150 million initial public offering last week.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *